* Outside of the USA, bioMérieux is simultaneously pursuing CE Mark certification for the BIOFIRE(®) Respiratory 2.1plus (RP2.1plus) panel, which also includes detection of MERS-CoV, on an accelerated timeline. Source text for Eikon: Further company coverage: (Reporting by Sudip Kar-Gupta)